Compare FLNA & CTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLNA | CTM |
|---|---|---|
| Founded | 1998 | 2019 |
| Country | United States | United States |
| Employees | 20 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.8M | 63.1M |
| IPO Year | N/A | 2022 |
| Metric | FLNA | CTM |
|---|---|---|
| Price | $1.25 | $0.70 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 346.0K | ★ 1.0M |
| Earning Date | 05-13-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 83.33 |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $52,866,001.00 |
| Revenue This Year | N/A | $20.36 |
| Revenue Next Year | N/A | $6.37 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 18.10 |
| 52 Week Low | $1.16 | $0.48 |
| 52 Week High | $2.03 | $1.56 |
| Indicator | FLNA | CTM |
|---|---|---|
| Relative Strength Index (RSI) | 40.61 | 45.59 |
| Support Level | $1.16 | $0.63 |
| Resistance Level | $1.80 | $0.78 |
| Average True Range (ATR) | 0.10 | 0.06 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 4.41 | 15.17 |
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.
Castellum Inc is focused on building a successful technology services, solutions, and products company in the areas of cybersecurity, IT, electronic warfare, information warfare, system modernization, and information operations with businesses in the defense, federal, civilian, and commercial markets. Services include intelligence analysis, software development, software engineering, program management, strategic and mission planning, information assurance, cybersecurity and policy support, data analytics, and model-based systems engineering. The company maintains one operating and reportable segment, which is the delivery of products and services in the areas of information technology, electronic warfare, information warfare and cybersecurity in the governmental and commercial markets.